These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21241789)

  • 1. Development and in vitro-in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride.
    Naeem Aamir M; Ahmad M; Akhtar N; Murtaza G; Khan SA; Shahiq-uz-Zaman ; Nokhodchi A
    Int J Pharm; 2011 Apr; 407(1-2):38-43. PubMed ID: 21241789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro - in vivo evaluation of a new oral dosage form of tramadol hydrochloride--controlled-release capsules filled with coated pellets.
    Szkutnik-Fiedler D; Balcerkiewicz M; Sawicki W; Grabowski T; Grześkowiak E; Mazgalski J; Urjasz H
    Acta Pol Pharm; 2014; 71(3):469-75. PubMed ID: 25265827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticulate drug delivery system containing tramadol hydrochloride for pain treatment.
    Ciurba A; Todoran N; Vari CE; Lazăr L; Al Hussein S; Hancu G
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1135-42. PubMed ID: 25581980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability between two Tramadol once-daily oral formulations.
    Hernandez-Lopez C; Martinez-Farnos L; Karhu D; Perez-Campos T; Rovira S; Encina G
    Methods Find Exp Clin Pharmacol; 2006; 28(6):373-8. PubMed ID: 16894407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, development and in vitro-in vivo study of tramadol-paracetamol inlay tablets.
    Kotta S; Bijumol C; Anitha Y; Dileep KJ; Valsala K
    Pharm Dev Technol; 2014 Feb; 19(1):1-9. PubMed ID: 23249424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of oral suspensions of microparticles of ethylcellulose with tramadol.
    Morales ME; Ruiz MA; López G; Gallardo V
    Drug Dev Ind Pharm; 2010 Aug; 36(8):885-92. PubMed ID: 20184418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
    Tamilvanan S; Sa B
    PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers.
    Silva Mde F; Schramm SG; Kano EK; Mori Koono EE; Porta V; dos Reis Serra CH
    Clin Ther; 2010 Apr; 32(4):758-65. PubMed ID: 20435245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tramadol and its major metabolites in alpacas following intravenous and oral administration.
    Edmondson MA; Duran SH; Boothe DM; Stewart AJ; Ravis WR
    J Vet Pharmacol Ther; 2012 Aug; 35(4):389-96. PubMed ID: 21883285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of tramadol sustained release capsules. 2nd communication: investigation of relative bioavailability and food interaction.
    Raber M; Schulz HU; Schürer M; Bias-Imhoff U; Momberger H
    Arzneimittelforschung; 1999 Jul; 49(7):588-93. PubMed ID: 10442206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of tramadol sustained release capsules. 1st communication: investigation of dose linearity.
    Schulz HU; Raber M; Schürer M; Amschler S; Momberger H
    Arzneimittelforschung; 1999 Jul; 49(7):582-7. PubMed ID: 10442205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of a once-daily tramadol extended-release tablet and an immediate-release reference product following single-dose and multiple-dose administration.
    Karhu D; Fradette C; Potgieter MA; Ferreira MM; Terblanché J
    J Clin Pharmacol; 2010 May; 50(5):544-53. PubMed ID: 20051587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments.
    Traynor MJ; Brown MB; Pannala A; Beck P; Martin GP
    Drug Dev Ind Pharm; 2008 Aug; 34(8):885-9. PubMed ID: 18618305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of oral tramadol pharmacokinetics in horses.
    Cox S; Villarino N; Doherty T
    Res Vet Sci; 2010 Oct; 89(2):236-41. PubMed ID: 20223494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
    Petrides PE; Gisslinger H; Steurer M; Linkesch W; Krumpl G; Schüller A; Widmann R
    Clin Ther; 2009 Feb; 31(2):386-98. PubMed ID: 19302911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.